A Blue-Chip Starter Portfolio: GlaxoSmithKline plc, Royal Dutch Shell Plc And BHP Billiton plc

How do GlaxoSmithKline plc (LON:GSK), Royal Dutch Shell Plc (LON:RDSB), BHP Billiton plc (LON:BLT) and the UK’s other seven industry giants shape up as a starter portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Every quarter I take a look at the largest FTSE 100 companies in each of the index’s 10 industries to see how they shape up as a potential “starter” portfolio.

The table below shows the 10 industry heavyweights and their current valuations based on forecast 12-month price-to-earnings (P/E) ratios and dividend yields.

Company Industry Recent share price (p) P/E Yield (%)
ARM Holdings Technology 1,037 29.9 0.9
BHP Billiton (LSE: BLT) Basic Materials 1,249 18.8 6.4
British American Tobacco Consumer Goods 3,415 15.6 4.7
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) Health Care 1,322 15.7 6.1
HSBC Holdings Financials 570 10.5 5.9
National Grid Utilities 817 13.8 5.4
Rolls-Royce Industrials 870 14.3 2.9
Royal Dutch Shell (LSE: RDSB) (NYSE: RDS-B.US) Oil & Gas 1,807 12.2 6.6
Vodafone Telecommunications 230 39.7 5.1
WPP Consumer Services 1,426 14.4 3.2

Historically, to get a feel for overall value, I’ve tracked the average P/E and yield of the “portfolio”, but excluding ARM with its typically lofty technology-sector valuation. However, for the past 18 months — since its mega-sale of Verizon Wireless — Vodafone’s valuation has also been anomalously high.

The table below shows the average portfolio P/E and yield at my quarterly review dates, including Vodafone (columns two and three) and excluding Vodafone (columns four and five).

  P/E Yield (%) P/E Yield (%)
July 2015 17.2 5.1 14.4 5.2
April 2015 17.2 4.9 14.9 4.8
January 2015 15.8 4.8 13.5 4.8
October 2014 15.0 4.7 13.1 4.6
July 2014 14.8 4.7 13.2 4.5
April 2014 13.6 4.6 12.8 4.6
January 2014 13.6 4.5 12.7 4.5
October 2013 12.2 4.7 12.1 4.7
July 2013 11.8 4.7 11.9 4.6
April 2013 12.3 4.6 12.4 4.4
January 2013 11.4 4.9 11.7 4.6
October 2012 11.1 5.0 11.1 4.7
July 2012 10.7 5.0 10.7 4.7
October 2011 9.8 5.2 9.8 5.0

My rule of thumb for the group of companies is that an average P/E below 10 is bargain territory, 10-14 is decent value, while above 14 starts to move towards expensive.

Last quarter I highlighted the growing disconnect between P/E and yield, suggesting:

“It may be that we’ll see a period of little or no dividend growth among the heavyweights (or even a rebasing of some dividends) to bring the yield down to a level that better reflects the high P/E and a low interest-rate environment in which other assets are yielding very little”.

This is starting to happen, although the average yield currently remains high. Since my April review, GlaxoSmithKline has announced it is pegging its dividend at an unchanged 80p a share for the next three years, while Shell has suggested its dividend may be flat at $1.88 for the next two years.

Nevertheless, I’d say the visibility these two companies have given us on their dividends and their high yields (Glaxo, 6.1% and Shell 6.6%) make them attractive for long-term investors at current price levels. Glaxo expects to return to earnings growth in 2016, guiding on annual growth for the period 2016-20 of mid-to-high single digits. Shell’s in-progress acquisition of BG Group should also drive earnings growth further down the line.

Miner BHP Billiton is another company where the short-term outlook is uninspiring, but the longer-term prospects much brighter. Billiton’s P/E of 18.8 is high, but, counterintuitively, high P/Es for miners can signal good times ahead for the share price and low P/Es the reverse. Three years ago, Billiton’s P/E was just 7.6 at a share price of 1,806p; the shares are now trading at 1,249p. Billiton’s current yield of 6.4% is also attractive, although the dividend may be vulnerable to the same lack of near-term growth as Glaxo and Shell, or even a re-basing.

Elsewhere, ARM, National Grid and HSBC, which I highlighted for you last quarter, continue to look attractive. ARM’s current P/E has dipped below 30 for the first time since I’ve been tracking the shares. National Grid’s P/E and yield are at value levels not seen since my October 2013 review. HSBC continues to have the lowest P/E of all 10 companies and a well-above-average yield.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline, HSBC and ARM Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

This 1 simple investing move accelerated Warren Buffett’s wealth creation

Warren Buffett has used this easy to understand investing technique for decades -- and it has made him billions. Our…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Down 6% in 2 weeks, the Lloyds share price is in reverse

After hitting a one-year high on 8 April, the Lloyds share price has suddenly reversed course. But as a long-term…

Read more »

Investing Articles

£3,000 in savings? Here’s how I’d use that to start earning a monthly passive income

Our writer digs into the details of how spending a few thousand pounds on dividend shares now could help him…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »